Peptide-Linked 1,3-Dialkyl-3-acyltriazenes: Gastrin Receptor Directed Antineoplastic Alkylating Agents

Journal of Medicinal Chemistry
1994.0

Abstract

The gastrin receptor is expressed in various human cancers, such as the adenocarcinoma of the colon. The peptide hormone gastrin and the C-terminal peptides derived from it act as growth factors for these cancers. The hypothesis for the present work was to use the gastrin receptor as a target for appropriately constructed cytotoxic agents. We developed methods to link tetragastrin and pentagastrin by their N-termini to cytotoxic 1-(2-chloroethyl)-3-benzyl-3-succinoyltriazene. These compounds, CBS-4 and CBS-5, respectively, whose complete structures were determined by multinuclear NMR and mass spectrometry, competed effectively with gastrin in an assay using either guinea pig stomach fundus or the rat acinar tumor cell line AR42J as the source of the receptor. CBS-5 was cytotoxic to AR42J cells but was not toxic to A549 human lung cancer cells, which do not express the receptor.

Knowledge Graph

Similar Paper

Peptide-Linked 1,3-Dialkyl-3-acyltriazenes: Gastrin Receptor Directed Antineoplastic Alkylating Agents
Journal of Medicinal Chemistry 1994.0
Synthesis and biological activity of new peptide segments of gastrin exhibiting gastrin antagonist property
Journal of Medicinal Chemistry 1984.0
Synthesis and anti-gastric cancer activity evaluation of novel triazole nucleobase analogues containing steroidal/coumarin/quinoline moieties
European Journal of Medicinal Chemistry 2019.0
New cyclic somatostatin analogues containing a pyrazinone ring: Importance of Tyr for antiproliferative activity
Bioorganic & Medicinal Chemistry Letters 2008.0
Squaramides with cytotoxic activity against human gastric carcinoma cells HGC-27: synthesis and mechanism of action
MedChemComm 2016.0
Design and synthesis of new triazoles linked to xanthotoxin for potent and highly selective anti-gastric cancer agents
Bioorganic & Medicinal Chemistry Letters 2017.0
Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe
Bioorganic & Medicinal Chemistry Letters 2016.0
Discovery and Characterization of 1H-1,2,3-Triazole Derivatives as Novel Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy
Journal of Medicinal Chemistry 2020.0
Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers
European Journal of Medicinal Chemistry 2021.0
Synthesis and biological evaluation of new [1,2,4]triazolo[4,3-a]pyridine derivatives as potential c-Met inhibitors
Bioorganic & Medicinal Chemistry 2016.0